… To assess whether our findings were robust, we also compared the incidence of inhibitor
development according to the product brands used at the first exposure to factor VIII (a time-…

… even prevent inhibitor development in hemophilia patients. … 13 European and 1 Canadian
hemophilia treatment centers, we … inhibitor development, we plotted the cumulative incidences …

… Inhibitor development in non-severe hemophilia is associated with increased mortality. High
rates of hemophilia… the impact of inhibitor development on non-severe HA patients. This is …

… The plasma-derived products containing von Willebrand factor were recently suggested to
determine a lower incidence of inhibitor development than recombinant products in PUPs, in …

… Background: Different rates of inhibitor development after either plasma‐derived (… the
incidence rates of inhibitor development in previously untreated patients (PUPs) with hemophilia A …

… to assess inhibitor development according to clotting factor concentrate in severe haemophilia
A … The cumulative incidence of inhibitor development in PUPs according to product was …

… incidence of inhibitor development among hemophilia A patients in The Netherlands, particularly
among patients … This increased incidence is likely to be associated with the usage of a …

… Incidence of inhibitor development in patients that received intensive treatment with FVIII
concentrates for surgery was compared with the incidence of inhibitor development in others …

… Although we observed a slightly higher incidence of inhibitors in patients who were first
treated during the first 6 months of life, we did not find a clearly decreasing trend in …

… The incidence rate of inhibitor development in these previously treated patients with hemophilia
A, treated on at least 150 exposure days, has been estimated to be ~2 per 1000 patient-…